Department of Chemistry
Apr. 9, 2020—As universities across the country pool resources to tackle pressing challenges brought on by COVID-19, individuals in the Department of Chemistry at Vanderbilt are working to develop one resource in high demand: hand sanitizer.
Acorn School teachers, chemistry department administrator honored with Chancellor’s Heart and Soul awards
Nov. 15, 2019—Kennadria Lloyd and Crystal Macias, two teachers at The Acorn School, and Magdalena Paszewska, administrative officer in the Department of Chemistry, are the latest recipients of the Chancellor’s Heart and Soul Staff Appreciation Award.
Sep. 26, 2019—Tony Capra, Lisa Fazio and Renã A.S. Robinson have been selected as Chancellor’s Public Voices Fellows for the spring 2020 semester.
Sep. 6, 2018—Thomas Floyd “Tommy” Howe Jr., who served as the scientific glassblower for Vanderbilt’s Department of Chemistry for 30 years, died June 29 in Nashville. He was 76. During his three decades at the university, Howe made major contributions to the chemistry department’s teaching and research programs as well as to other science departments in the...
Sep. 14, 2017—The Office of the Provost, as part of the Provost's Initiative to Enhance Research and Scholarship (PIERS), is providing a campuswide educational workshop Oct. 9 to support the diversification of faculty research portfolios.
Mar. 23, 2016—Dean of the College of Arts and Science Lauren Benton has announced the appointment of two senior faculty members as divisional deans in the college. The new positions will facilitate academic planning in departments and programs within the three Arts and Science divisions: humanities, social sciences and sciences.
Jan. 21, 2016—Vanderbilt investigators have developed a way to detect malaria that is faster and more sensitive than current clinical methods — a development that has the potential to make malaria detection significantly less expensive and more stable.
Oct. 22, 2015—Walter Chazin, Ph.D., director of the Vanderbilt Center for Structural Biology, is a recipient of a 2016 Fellow of the Biophysical Society award.
Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.